Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VCP | P55072 | 6/20 | 0.56 |
| ▸ | FBP1 | P09467 | 10/20 | 0.55 |
| ▸ | EGFR | P00533 | 2/20 | 0.52 |
| ▸ | SYK | P43405 | 2/20 | 0.52 |
| ▸ | GALR2 | O43603 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.52 |
| ▸ | ABL1 | P00519 | 1/20 | 0.45 |
| ▸ | ABL2 | P42684 | 1/20 | 0.45 |
| ▸ | TLR4 | O00206 | 3/20 | 0.44 |
| ▸ | TLR2 | O60603 | 3/20 | 0.44 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL233939 | 1.00 | VCP (0.56) | VCPFBP1EGFRSYKGALR2 | |
| SCHEMBL29279535 | 0.80 | FBP1 (0.54) | VCPFBP1EGFRSYKGALR2 | |
| SCHEMBL29279591 | 0.80 | FBP1 (0.54) | VCPFBP1EGFRSYKGALR2 | |
| SCHEMBL2791518 | 0.76 | TYR (0.44) | ALDH1A1LMNAMAPTMAPK1HTT | |
| SCHEMBL1172170 | 0.76 | TYR (0.44) | ALDH1A1LMNAMAPTMAPK1HTT | |
| SCHEMBL1172169 | 0.76 | TYR (0.44) | ALDH1A1LMNAMAPTMAPK1HTT | |
| SCHEMBL360286 | 0.74 | ALDH1A1 (0.47) | ALDH1A1LMNAMAPTHTTSMN1; SMN2 | |
| SCHEMBL15475023 | 0.73 | TUBB1 (0.51) | ALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL15475022 | 0.73 | TUBB1 (0.51) | ALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL793160 | 0.72 | VCP (1.00) | VCPFBP1EGFRSYKGALR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2718458-B1 | NOVEL METHOD FOR DETECTION OF BETA-D-GLUCURONIDASE | BIOSYNTH AG (CH) | 2015-07-08 | — | — | EP | claimed |
| US-20140212905-A1 | Novel Method for Detection of Beta-D-Glucuronidase | BIOSYNTH AG (CH) | 2014-07-31 | — | — | US | claimed |
| EP-2718458-A1 | NOVEL METHOD FOR DETECTION OF BETA-D-GLUCURONIDASE | Biosynth AG (CH) | 2014-04-16 | — | — | EP | claimed |
| WO-2012168415-A1 | NOVEL METHOD FOR DETECTION OF BETA-D-GLUCURONIDASE | BIOSYNTH AG (CH) | 2012-12-13 | — | — | WO | claimed |
| EP-2532753-A1 | Method for detection of beta-D-glucuronidase | Biosynth AG (CH) | 2012-12-12 | — | — | EP | claimed |
| EP-0097506-A2 | Method for diagnosis of mastitis using enzyme N-acetyl-beta-D-glucosaminidase and reaction systems for use in method | The State of Queensland (AU) | 1984-01-04 | — | — | EP | claimed |
| EP-4376887-A2 | MATERIALS AND METHODS OF MAKING OR USING IL-23R BINDING PROTEINS | Janssen Biotech, Inc. (US) | 2024-06-05 | — | — | EP | disclosed |
| WO-2024112907-A1 | SYSTEMS, METHODS, AND KITS FOR DETECTING PROTEIN INTERACTIONS | ADVANCED CELL DIAGNOSTICS, INC. (US) | 2024-05-30 | — | — | WO | disclosed |
| US-20240035073-A1 | METHODS FOR DETECTING PROTEINS AND FOR CO-DETECTING PROTEINS AND NUCLEIC ACIDS, AND KITS FOR THE SAME | ADVANCED CELL DIAGNOSTICS, INC. | 2024-02-01 | — | — | US | disclosed |
| CN-111675761-B | Purpurin-4 binding proteins and methods of use thereof | 艾更斯司股份有限公司 | 2023-10-20 | — | — | CN | disclosed |
| EP-4225379-A1 | METHODS FOR TREATING CANCERS WITH ANTIBODY DRUG CONJUGATES (ADC) THAT BIND TO 191P4D12 PROTEINS | Agensys, Inc. (US) | 2023-08-16 | — | — | EP | disclosed |
| CN-108368543-B | In situ detection of nucleotide variants in high noise samples and related compositions and methods | 领先细胞医疗诊断有限公司 | 2023-06-13 | — | — | CN | disclosed |
| EP-4168039-A1 | MARKERS FOR USE IN METHODS FOR TREATING CANCERS WITH ANTIBODY DRUG CONJUGATES (ADC) | Agensys, Inc. (US) | 2023-04-26 | — | — | EP | disclosed |
| EP-2718458-A1 | NOVEL METHOD FOR DETECTION OF BETA-D-GLUCURONIDASE | Biosynth AG (CH) | 2014-04-16 | — | — | EP | disclosed |
| WO-2012168415-A1 | NOVEL METHOD FOR DETECTION OF BETA-D-GLUCURONIDASE | BIOSYNTH AG (CH) | 2012-12-13 | — | — | WO | disclosed |
| EP-2532753-A1 | Method for detection of beta-D-glucuronidase | Biosynth AG (CH) | 2012-12-12 | — | — | EP | disclosed |
| WO-2012006187-A2 | METHODS AND DEVICES FOR THE SELECTIVE DETECTION OF MICROORGANISMS | C3 JIAN, INC. (US) | 2012-01-12 | — | — | WO | disclosed |
| US-20120003661-A1 | METHODS AND DEVICES FOR THE SELECTIVE DETECTION OF MICROORGANISMS | C3 JIAN, INC. (US) | 2012-01-05 | — | — | US | disclosed |
| US-20060292559-A1 | Cell-based microarrays, and methods for their preparation and use | BECKMAN COULTER, INC. (US) | 2006-12-28 | — | — | US | disclosed |
| EP-0097506-A2 | Method for diagnosis of mastitis using enzyme N-acetyl-beta-D-glucosaminidase and reaction systems for use in method | The State of Queensland (AU) | 1984-01-04 | — | — | EP | disclosed |